Paper Details
- Home
- Paper Details
How often do we face side effects of sirolimus in pediatric renal transplantation?
Author: DalgicA, FidanK, GonulI I, KandurY, SozenH, SöylemezoğluO
Original Abstract of the Article :
We analyzed 25 pediatric renal transplantation patients on sirolimus (SRL) therapy to assess changes in serum creatinine, glomerular filtration rate, electrolytes, triglycerides, cholesterol, and side effects. Mean time to initiate SRL therapy was 3.2 years. The serum creatinine levels of patients o...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://doi.org/10.1016/j.transproceed.2012.08.005
データ提供:米国国立医学図書館(NLM)
Navigating the Sands of Sirolimus: Side Effects in Pediatric Renal Transplantation
The desert of pediatric renal transplantation is a complex and challenging landscape. This study explores the use of sirolimus, an immunosuppressant medication used to prevent rejection after kidney transplantation, in pediatric patients. The authors examined the impact of sirolimus therapy on various parameters, including serum creatinine, glomerular filtration rate, and side effects. The study aimed to better understand the potential benefits and risks of sirolimus treatment in this vulnerable population.A Closer Look at the Oasis: Sirolimus in Pediatric Renal Transplantation
This research provides valuable insights into the use of sirolimus in pediatric renal transplantation. The authors found that sirolimus therapy can effectively prevent rejection, offering a crucial tool for managing this complex condition. However, the study also highlights the potential for side effects, emphasizing the need for careful monitoring and personalized treatment strategies. This study serves as a guide for navigating the complexities of sirolimus therapy in pediatric patients, ensuring a more effective and safer approach to managing this condition.Crossing the Desert Safely: A Balanced Approach to Pediatric Renal Transplantation
The findings of this study underscore the importance of a careful and balanced approach to sirolimus therapy in pediatric renal transplantation. The authors provide valuable information on potential side effects, urging doctors to carefully monitor patients and adjust treatment accordingly. This research offers a valuable tool for navigating the complexities of pediatric renal transplantation, ensuring a safer and more effective journey for these young patients.Dr. Camel's Conclusion
This study provides valuable insights into the use of sirolimus in pediatric renal transplantation. It's like navigating a desert with a compass – we need to be mindful of potential hazards, carefully monitor our progress, and adjust our course accordingly. This research offers a valuable tool for ensuring a smoother and safer journey for these young patients, helping them navigate the desert of transplantation with a greater chance of success.Date :
- Date Completed 2013-08-28
- Date Revised 2013-11-21
Further Info :
Related Literature
Article Analysis
SNS
PICO Info
in preparation
Languages
English
Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.